Synthesis and intestinal transport of the iron chelator maltosine in free and dipeptide form
Authors:
- Michael HellwigMHMichael Hellwig
- Fritz MarkwardtFritz Markwardt
- Thomas HenleTHThomas Henle
- Matthias BrandschMBMatthias Brandsch
- 1 May 2011
- journal article
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 78 (1) , 75-82
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Beta-thalassemiaGenetics in Medicine, 2010
- Iron overload and toxicity: the hidden risk of multiple blood transfusionsVox Sanguinis, 2009
- Recent developments on 3-hydroxy-4-pyridinones with respect to their clinical applicationsCoordination Chemistry Reviews, 2008
- Iron chelating agents for the treatment of iron overloadCoordination Chemistry Reviews, 2008
- Bifunctional 3-hydroxy-4-pyridinone derivatives as potential pharmaceuticals: synthesis, complexation with Fe(III), Al(III) and Ga(III) and in vivo evaluation with 67GaJBIC Journal of Biological Inorganic Chemistry, 2005
- Iron chelating agents in clinical practiceCoordination Chemistry Reviews, 1999
- Effective chelation of iron in beta thalassaemia with the oral chelator 1,2-dimethyl-3-hydroxypyrid-4-one.BMJ, 1987
- 1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE, AN ORALLY ACTIVE CHELATOR FOR TREATMENT OF IRON OVERLOADThe Lancet, 1987
- Visual and Auditory Neurotoxicity in Patients Receiving Subcutaneous Deferoxamine InfusionsNew England Journal of Medicine, 1986
- NEW ORALLY ACTIVE IRON CHELATORSThe Lancet, 1985